7-Ketocholesterol and 5,6-secosterol modulate differently the stress-activated mitogen-activated protein kinases (MAPKs) in liver cells

Journal of Cellular Physiology

Volumn 222, Issue 3, 2010, Pages 586-595

  Anticoli, Simona ^a,b   Arciello, Mario ^a,b   Mancinetti, Adriano ^a,b   De Martinis, Massimo ^a   Ginaldi, Lia ^a   Iuliano, Luigi ^c   Balsano, Clara ^a,b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Laboratory of Molecular Virology and Oncology   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 SECOSTEROL; 7 OXOCHOLESTEROL; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYSTEROL; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL AGING; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL SURVIVAL; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIVER CELL; MODULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE REGENERATION;

APOPTOSIS; CASPASE 3; CELL AGING; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KETOCHOLESTEROLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; STEROLS; TIME FACTORS;

EID: 73649095857     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21972     Document Type: Article

References (40)

1. Albano E. 2008. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 29:9-16.
2. Arca M, Natoli S, Micheletta F, Riggi S, Di Angelantonio E, Montali A, Antonini TM, Antonini R, Diczfalusy U, Iuliano L. 2007. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med 42:698-705.
3. Barkla DH, Gibson PR. 1999. The fate of epithelial cells in the human large intestine. Pathology 31:230-238.
4. Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, Thiery J, Kan YW, Werner S. 2008. Impaired liver regeneration inNrf2 knockout mice: Role of ROS-mediated insulin/ IGF-1 resistance. EMBO J 27:212-223.
5. Biasi F, Leonarduzzi G, Vizio B, Zanetti D, Sevanian A, Sottero B, Verde V, Zingaro B, Chiarpotto E, Poli G. 2004. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: Implications for proatherogenic gene modulation. FASEB J 18:693-695.
6. Choi J, Ou JH. 2006. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:G847-G851.
7. Corradini SG, Micheletta F, Natoli S, Iappelli M, Di Angelantonio E, De Marco R, Elisei W, Siciliano M, Rossi M, Berloco P, Attili AF, Diczfalusy U, Iuliano L. 2005. High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transplant 11:1494-1504.
8. DasM, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci USA 104:15759-15764.
9. Diehl AM. 2002. Liver regeneration. Front Biosci 7:e301-e314.
10. Fausto N. 2000. Liver regeneration. J Hepatol 32:19-31.
11. Iwasa H, Han J, Ishikawa F. 2003. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8:131-144.
12. Javitt NB. 2008. Oxysterols: Novel biologic roles for the 21st century. Steroids 73:149-157.
13. Jung-Hynes B, AhmadN. 2009. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle 8:1478-1483.
14. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-661.
15. Kim DE, Youn YC, Kim YK, Hong KM, Lee CS. 2009. Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change. Neurochem Res 34:1433-1442.
16. Kwong J, Hong L, Liao R, Deng Q, Han J, Sun P. 2009. p38{alpha} and p38{gamma} mediate oncogenic ras-isnduced senescence through differential mechanisms. J Biol Chem 284:11237-11246.
17. Lemaire S, Lizard G, Monier S, Miguet C, Gueldry S, Volot F, Gambert P, Néel D. 1998. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 440:434-439.
18. Leonarduzzi G, Vizio B, Sottero B, Verde V, Gamba P, Mascia C, Chiarpotto E, Poli G, Biasi F. 2006. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid Redox Signal 8:375-380.
19. Lu T, Finkel T. 2008. Free radicals and senescence. Exp Cell Res 314:1918-1922.
20. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. 2000. Genes involved in senescence and immortalization. Curr Opin Cell Biol 12:705-709.
21. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. 2008. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 44:1259-1272.
22. Maruyama J, Naguro I, Takeda K, Ichijo H. 2009. Stress-activated MAP kinase cascades in cellular senescence. Curr Med Chem 16:1229-1235.
23. Mates JM. 2000. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153:83-104.
24. Matsuzawa A, Ichijo H. 2008. Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 1780:1325-1336.
25. McConnell BB, StarborgM, Brookes S, Peters G. 1998. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 8:351-354.
26. McCubrey JA, Lahair MM, Franklin RA. 2006. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8:1775-1789.
27. Miguet C, Monier S, Bettaieb A, Athias A, Besséde G, LaubrietA, Lemaire S, Néel D, Gambert P, Lizard G. 2001. Ceramide generation occurring during 7β-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ 8:83-99.
28. Moreira EF, Jaworski C, Li A, Rodriguez IR. 2001. Molecular and biochemical characterization of a novel oxysterolbinding protein (OSBP2) highly expressed in retina. J Biol Chem 276:18570-18578.
29. O'Callaghan YC, Woods JA, O'Brien NM. 1999. Oxysterol-induced cell death in U937 and HepG2 cells at reduced and normal serum concentrations. Eur J Nutr 38:255-262.
30. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. 2002. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122:366-375.
31. Pinzani M, Rombouts K. 2004. Liver fibrosis: From the bench to clinical targets. Dig Liver Dis 36:231-242.
32. Reid AE. 2001. Nonalcoholic steatohepatitis. Gastroenterology 121:710-723.
33. Roninson IB, Broude EV, Chang BD. 2001. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update 4:303-313.
34. Savouret JF, Antenos M, Quesne M, Xu J, Milgrom E, Casper RF. 2001. 7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J Biol Chem 276:3054-3059.
35. Schroepfer GJ, Jr. 2000. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 80:361-554.
36. Schwabe RF, Brenner DA. 2006. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: Role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:G583-G589.
37. Tanikawa K, Torimura T. 2006. Studies on oxidative stress in liver diseases: Important future trends in liver research. Med Mol Morphol 39:22-27.
38. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40.
39. Wada T, Stepniak E, Hui L, Leibbrandt A, Katada T, Nishina H, Wagner EF, Penninger JM. 2008. Antagonistic control of cell fates by JNK and p38-MAPK signaling. Cell Death Differ 15:89-93.
40. Weymann A, Hartman E, Gazit V, Wang C, Glauber M, Turmelle Y, Rudnick DA. 2009. p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 50:207-215.